|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/64 | (2017.01) |
| A61P 21/00 | (2006.01) |
| (11) | Number of the document | 3554554 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17832405.9 |
| Date of filing the European patent application | 2017-12-14 | |
| (97) | Date of publication of the European application | 2019-10-23 |
| (45) | Date of publication and mention of the grant of the patent | 2022-09-07 |
| (46) | Date of publication of the claims translation | 2022-11-25 |
| (86) | Number | PCT/US2017/066351 |
| Date | 2017-12-14 |
| (87) | Number | WO 2018/118627 |
| Date | 2018-06-28 |
| (30) | Number | Date | Country code |
| 201662436199 P | 2016-12-19 | US | |
| 201762443481 P | 2017-01-06 | US | |
| 201762479177 P | 2017-03-30 | US | |
| 201762562119 P | 2017-09-22 | US |
| (72) |
PASSINI, Marco, A. , US
HANSON, Gunnar, J. , US
|
| (73) |
Sarepta Therapeutics, Inc. ,
215 First Street, Suite 415, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Egzoną praleidžiantys oligomero konjugatai nuo raumenų distrofijos |
| EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY |
| Payment date | Validity (years) | Amount | |
| 2024-11-22 | 8 | 185.00 EUR |
| 2025-12-14 |